Publications by authors named "M Zwolinska-Wcislo"
Background: Liver diseases are among the most commonly diagnosed conditions, with the main risk factors being inappropriate lifestyles, including poor diet, excessive alcohol consumption, low physical activity and smoking, including electronic cigarettes. Non-communicable chronic liver diseases also often develop as a result of accompanying overweight and obesity, as well as type 2 diabetes.
Methods: The literature on risk factors for non-communicable chronic liver diseases, which show a high strong influence on their occurrence, was analysed.
Alcohol-associated liver disease (ALD) remains a major and increasingly pressing concern in hepatology. ALD includes spectrum of conditions, each with unique diagnostic and therapeutic challenges. Excessive alcohol intake is a leading preventable cause of physical harm, including ALD.
View Article and Find Full Text PDFObjective: Evaluation of serum lactadherin level, its correlation with disease activity and certain biochemical parameters in IBD patients.
Methods: The study involved adult IBD patients, comprising 50 with ulcerative colitis (UC), 68 with Crohn's disease (CD), and 29 healthy controls.
Results: The MFGE8 median concentration was significantly higher in UC versus controls (1914.
remains a major health problem worldwide, causing considerable morbidity and mortality due to peptic ulcer disease and gastric cancer. These guidelines constitute an update of the previous "Recommendations on the diagnosis and management of infection" issued in 2014. They have been developed by a Task Force organized by the Governing Board of the Polish Society of Gastroenterology.
View Article and Find Full Text PDFArticle Synopsis
- Pyoderma gangrenosum (PG) is an auto-inflammatory skin condition that leads to painful ulcers, as seen in a 31-year-old woman with Crohn's disease.
- She experienced severe skin ulcers for a month and underwent various treatments, including steroids and adalimumab, but saw no improvement.
- The patient then participated in a clinical trial with ustekinumab, an anti-cytokine drug, resulting in significant symptom relief and no relapse, suggesting its potential for treating PG, especially in patients with autoimmune diseases.